ACTIVExtend: 24 months of alendronate after 18 months of abaloparatide or placebo for postmenopausal osteoporosis
Journal of Clinical Endocrinology & Metabolism | Aug 12, 2018
Spotlight on certolizumab pegol in the treatment of axial spondyloarthritis: Efficacy, safety and place in therapy
Open Access Rheumatology: Research and Reviews | May 25, 2018
Most read this week